Company Update GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Glenmark receives ANDA approval for Topiramate Capsules USP, 15 mg & 25 mg